Delivery Order SPE2DB22D2206-SPE2DB25FJD46
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.22 firm-fixed-price contract is for the delivery of 1 gram vials of the antibiotic Meropenem in 0.9% sodium chloride solution. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Meropenem-0.9% Sodium Chloride 1 gram/50s, a type of antibiotic medication. The contract has a firm fixed price of $1,464.38 and a completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,269.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Ertapenem 1 gram vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 22, 2025, and represents a small-value pharmaceutical procurement with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of ertapenem 1 gram vials, a broad-spectrum antibiotic used in military and federal healthcare systems. This firm fixed price delivery order, valued at $1,849.37, represents a competitively awarded procurement with no set-aside designation and is scheduled for completion by July 28, 2025. The order is being fulfilled from AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ertapenem 1 gram vials with a ceiling value of $1,146.98. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, representing a straightforward pharmaceutical procurement to support federal medical requirements. The order is scheduled for completion by July 22, 2025, with performance taking place at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,404.20 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical products and medical supplies. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,523.65 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a small-value pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,251.31 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and is performing work at its...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD46Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order represents a single transaction under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide spectrum of medications, vaccines, and medical supplies to support military healthcare systems and other federal health agencies worldwide. AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition, combined with its extensive experience as a major healthcare solutions provider, positions it as a key vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/30/25 |